Study: Cancer survival rates not linked to Medicare spending

03/13/2013 | HealthDay News

Medicare data show that average spending on patients with advanced lung, colorectal, pancreas, breast and prostate cancers varied by up to 41% across U.S. regions but had no direct effect on survival, researchers reported in the Journal of the National Cancer Institute. The Dana-Farber Cancer Institute study showed that inpatient hospitalization was an important factor in regional spending variation.

View Full Article in:

HealthDay News

Published in Briefs:

SmartBrief Job Listings for Health Care